Botswana’s Ministry of Health is taking significant steps to improve the country’s healthcare system by addressing medicine shortages, reforming procurement processes and strengthening the supply of essential drugs. Acting Permanent Secretary in the Ministry of Health, Dr Tshepo Machacha, confirmed that expired medicines and drugs valued at more than P95 million were recently destroyed at the Central Medical Stores. The announcement was made during his appearance before the Public Accounts Committee, where he provided an update on the government’s efforts to improve the availability of medicines across public healthcare facilities. His remarks highlighted both the challenges facing the healthcare system and the measures being introduced to ensure patients receive the treatment they need. The developments mark an important phase in Botswana’s efforts to improve efficiency, reduce costs and restore confidence in the national medicine supply chain.
The destruction of expired medicines worth over P95 million underscores the importance of effective inventory management within the healthcare sector. Medicines have limited shelf lives and must be disposed of safely once they expire to protect public health and maintain medical safety standards. While the disposal of expired stock represents a financial loss, it also demonstrates the government’s commitment to ensuring that only safe and effective medicines are available for use in hospitals and clinics. Proper disposal prevents expired pharmaceutical products from entering circulation, where they could pose serious health risks to patients. The incident also raises the need for stronger forecasting, improved stock monitoring and better coordination throughout the medicine supply chain.
Addressing medicine shortages remains one of the government’s highest priorities as healthcare facilities continue working to meet patient demand. Dr Machacha assured the Public Accounts Committee that the Ministry of Health is working around the clock to resolve shortages affecting hospitals across Botswana. He noted that critical medicines used to treat Non Communicable Diseases have already arrived at various health facilities throughout the country. This development offers reassurance to thousands of patients who depend on consistent access to medication for chronic conditions such as diabetes, hypertension, cardiovascular diseases and other long-term illnesses. Reliable access to these medicines is essential for improving patient outcomes, preventing complications and reducing unnecessary hospital admissions.
The availability of medicines for Non Communicable Diseases is particularly important because these conditions continue to place increasing pressure on healthcare systems around the world. Effective management of chronic illnesses depends on uninterrupted treatment and regular access to prescribed medication. Delays or shortages can negatively affect patients’ health, increase healthcare costs and place additional strain on hospitals and medical professionals. By prioritizing the delivery of these critical medicines, the government aims to improve continuity of care and ensure patients receive appropriate treatment without unnecessary interruptions. Strengthening medicine availability also contributes to broader public health goals by supporting disease management and improving quality of life.
Another major development announced by Dr Machacha is Botswana’s decision to procure medicines from the United Arab Emirates, where prices are reported to be nearly 40 percent lower than those offered by previous suppliers. Reducing procurement costs could generate significant savings for the healthcare system while allowing government resources to be used more efficiently. Lower purchasing costs may also create opportunities to expand the range of medicines available and improve stock levels at public healthcare facilities. Cost-effective procurement is an important component of sustainable healthcare financing, particularly as demand for medicines continues to grow. By exploring new international suppliers, Botswana is seeking to improve affordability without compromising the quality of essential medicines.
Dr Machacha also identified one of the most significant challenges affecting medicine procurement, namely the presence of middlemen within the Ministry of Health’s procurement system. According to his remarks, intermediaries have contributed to inflated medicine prices, increasing costs for the government and reducing overall efficiency within the supply chain. Eliminating unnecessary intermediaries could simplify procurement processes, improve transparency and ensure better value for public funds. Direct procurement arrangements may also shorten delivery times while strengthening accountability throughout the purchasing process. Addressing these structural challenges will be essential for creating a more reliable and financially sustainable healthcare procurement system.
The government’s ongoing procurement reforms reflect a broader commitment to improving governance, financial management and service delivery within the health sector. Public healthcare systems rely on transparent procurement processes to ensure essential medicines are purchased at competitive prices and delivered on time. Strengthening oversight, improving planning and adopting more efficient procurement strategies can reduce waste while increasing the availability of medicines for patients. These reforms also support responsible use of taxpayer funds by ensuring healthcare budgets achieve the greatest possible impact. Building a more efficient procurement system ultimately benefits patients, healthcare workers and the country’s overall health infrastructure.
Botswana’s latest measures demonstrate a clear determination to address both immediate medicine shortages and the long-term challenges affecting pharmaceutical procurement. The destruction of expired medicines, the arrival of critical drugs for Non Communicable Diseases, the move toward more affordable suppliers in the United Arab Emirates and efforts to eliminate costly middlemen all form part of a wider strategy to strengthen the healthcare system. While significant work remains, these initiatives represent meaningful progress toward improving access to essential medicines and ensuring greater efficiency within the public health sector. Continued investment in procurement reform, supply chain management and transparent governance will be critical to achieving lasting improvements. As these efforts continue, Botswana is working to build a healthcare system that provides reliable, affordable and high-quality medical services for all its citizens.
